SCM
MRK icon

SKBA Capital Management’s Merck MRK Stock Holding History

SKBA Capital Management’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.2M Sell
118,272
-33,600
-22% -$3.93M 2.51% 10
2026
Q1 		$18.3M Hold
151,872
– – 2.51% 12
2025
Q4 		$16M Sell
151,872
-13,530
-8% -$1.27M 2.27% 14
2025
Q3 		$13.9M Sell
165,402
-1,370
-0.8% -$113K 1.92% 20
2025
Q2 		$13.2M Sell
166,772
-370
-0.2% -$29.4K 1.9% 21
2025
Q1 		$15M Buy
167,142
+1,487
+0.9% +$139K 2.23% 10
2024
Q4 		$16.5M Sell
165,655
-6,900
-4% -$711K 2.6% 7
2024
Q3 		$19.6M Sell
172,555
-1,200
-0.7% -$143K 2.91% 6
2024
Q2 		$21.5M Sell
173,755
-2,500
-1% -$322K 3.45% 2
2024
Q1 		$23.3M Sell
176,255
-1,380
-0.8% -$170K 3.64% 2
2023
Q4 		$19.4M Buy
177,635
+12,300
+7% +$1.28M 3.26% 4
2023
Q3 		$17M Sell
165,335
-100
-0.1% -$10.8K 3.14% 3
2023
Q2 		$19.1M Sell
165,435
-21,900
-12% -$2.49M 3.44% 2
2023
Q1 		$19.9M Sell
187,335
-700
-0.4% -$75.6K 3.71% 1
2022
Q4 		$20.9M Sell
188,035
-190
-0.1% -$19.4K 3.86% 1
2022
Q3 		$16.2M Buy
188,225
+700
+0.4% +$62.5K 3.44% 3
2022
Q2 		$17.1M Sell
187,525
-200
-0.1% -$17.7K 3.42% 3
2022
Q1 		$15.4M Buy
187,725
+1,100
+0.6% +$86.7K 2.78% 8
2021
Q4 		$14.3M Buy
186,625
+28,900
+18% +$2.3M 2.69% 8
2021
Q3 		$11.8M Buy
157,725
+1,575
+1% +$120K 2.36% 13
2021
Q2 		$12.1M Sell
156,150
-48,629
-24% -$3.62M 2.38% 13
2021
Q1 		$15.1M Buy
204,779
+23,161
+13% +$1.71M 2.39% 10
2020
Q4 		$14.2M Buy
181,618
+120,205
+196% +$9.19M 2.37% 10
2020
Q3 		$4.86M Buy
+61,413
New +$4.81M 0.97% 50

Other funds holding MRK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

SKBA Capital Management's MRK Position: Q2 2026 in Review

SKBA Capital Management reduced its Merck (MRK) stake by 22% in Q2 2026, selling an estimated $3.93M and leaving 118,272 shares worth $15.2M. The position accounts for 2.51% of the portfolio, ranked #10.

SKBA Capital Management first reported a position in MRK in Q3 2020 and has held it in 24 quarters since. The position peaked at $23.3M in Q1 2024. 3,833 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • SKBA Capital Management held 118,272 shares of Merck worth $15.2M as of Q2 2026.
  • SKBA Capital Management sold 33,600 Merck shares in Q2 2026, an estimated $3.93M.
  • Merck made up 2.51% of SKBA Capital Management's portfolio in Q2 2026, its #10 holding.
  • SKBA Capital Management first reported a position in Merck in Q3 2020 and has held it in 24 quarters since.
  • SKBA Capital Management's Merck position peaked at $23.3M in Q1 2024.
  • 3,833 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on SKBA Capital Management's 13F filing for Q2 2026, filed 11 Aug 2026.